ICPT : Analysis & Opinions

  1. Will This Drug Beat Gilead to Market in NASH?

    May 22, 2015
    A race of sorts is on between Gilead Sciences (NASDAQ: GILD) and Intercept Pharmaceuticals (NASDAQ: ICPT). In a bid to be ...
  2. Meet The 5 Companies Loving Obamacare

    November 4, 2014
  3. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
Trading Center